Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter eradication to prevent ulcer bleeding in aspirin users
2011-003425-96Phase 4Unknown
- Sponsor
- University of Nottingham
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lansoprazole + metronidazole + clarithromycin in Helicobacter pylori infection and Peptic ulcer disease (PUD) (2 arms), sponsored by University of Nottingham. Primary endpoint: Hospitalisation due to peptic ulcer bleeding. Status: unknown.
02
Drugs
lansoprazole + metronidazole + clarithromycin
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on 2011-003425-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003425-96.